A Trial of Ferumoxytol for the Treatment of Iron Deficiency Anemia in Pediatric Participants With Nondialysis-Dependent Chronic Kidney Disease

NCT01155388 · clinicaltrials.gov ↗
PHASE3
Phase
TERMINATED
Status
14
Enrollment
INDUSTRY
Sponsor class

Stopped Several factors contributed to significant challenges in enrollment and led the Sponsor to discontinue the AMAG-FER-CKD-252 study as designed.

Conditions

Interventions

Sponsor

AMAG Pharmaceuticals, Inc.